Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
David M. Mintzer, MD

David M. Mintzer, MD Physician

Associate Director, CREP Program
Chief, Section of Hematology-Oncology, Pennsylvania Hospital
Director, Palliative Care
Clinical Professor of Medicine

Dr. Mintzer is a Penn Medicine employed physician.

About Dr. David M. Mintzer

Recognized annually in Philadelphia Magazine's Top Docs issue from 2004 through 2016

Recognized by Best Doctors in America 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014

Recognized by Suburban Life magazine's "Top Physicians 2010" issue

Recognized in America's Top Doctors, 2008, 2010, 2011-14

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

  • Breast Cancer Program

Board Certification:

  • Hematology, 1982
  • Hospice and Palliative Medicine, 2012
  • Internal Medicine, 1980
  • Medical Oncology, 1983

Clinical Expertise:

  • Anal Cancer
  • Breast Cancer
  • Cancer Pain Management
  • Colon Cancer
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastrointestinal Cancer
  • Gastrointestinal Carcinoid Tumor
  • Head and Neck Cancer
  • Hospice
  • Kidney Cancer
  • Liver Cancer
  • Palliative Care
  • Pancreatic Cancer
  • Prostate Cancer
  • Rectal Cancer
  • Sinus Cancer
  • Small Intestine Cancer
  • Stomach Cancer (Gastric Cancer)
  • Testicular Cancer
  • Urologic Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Jefferson Medical College
Residency: Pennsylvania Hospital
Fellowship: Thomas Jefferson University Hospital
Fellowship: Memorial Sloan-Kettering Cancer Center


American College of Physicians, National American Society of Clinical Oncology, National American Society of Hematology, National

Hospital Affiliation

Dr. Mintzer is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Granda-Cameron C, Behta M, Hovinga M, Rundio A, Mintzer D.: Risk factors associated with unplanned hospital readmissions in adults with cancer. Oncol Nurs Forum 42 (3): E257-68,2015.

Mintzer D: Generalizations of a generalist Journal of Community and Supportive Oncology in press : 2015.

Raess Philipp W, Mintzer David, Husson Michael, Nakashima Megan O, Morrissette Jennifer J D, Daber Robert, Bagg Adam: BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia. Blood 122 (17): 3084-5,2013.

Mintzer David M: Oncodoxes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31 (3): 393-4,2013.

Dotan Efrat, Meropol Neal J, Burtness Barbara, Denlinger Crystal S, Lee James, Mintzer David, Zhu Fang, Ruth Karen, Tuttle Holly, Sylvester Judi, Cohen Steven J: A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study. Journal of gastrointestinal cancer 43 (4): 562-9,2012.

Schwartzberg Lee S, Arena Francis P, Mintzer David M, Epperson Amanda L, Walker Mark S: Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer. Clinical breast cancer 12 (2): 87-93,2012.

Granda-Cameron Clara, DeMille Debra, Lynch Mary Pat, Huntzinger Christine, Alcorn Theresa, Levicoff Joan, Roop Carly, Mintzer David: An interdisciplinary approach to manage cancer cachexia. Clinical journal of oncology nursing 14 (1): 72-80,2010.

Mintzer David M, Zheng Sarah, Nagamine Michiko, Newman Jason, Benito Maria: Esthesioneuroblastoma (Olfactory Neuroblastoma) with Ectopic ACTH Syndrome: a multidisciplinary case presentation from the Joan Karnell cancer center of Pennsylvania Hospital. The oncologist 15 (1): 51-8,2010.

Mintzer David M, Billet Shira N, Chmielewski Lauren: Drug-induced hematologic syndromes. Advances in hematology 2009 : 495863,2009.

Borghaei Hossein, Langer Corey J, Millenson Michael, Ruth Karen J, Litwin Samuel, Tuttle Holly, Seldomridge Judie Sylvester, Rovito Marc, Mintzer David, Cohen Roger, Treat Joseph: Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 3 (11): 1286-92,2008.

Academic Contact Info

Pennsylvania Hospital
Abramson Cancer Center at Pennsylvania Hospital
Farm Journal Building
230 West Washington Square, 2nd Floor

Philadelphia, PA 19106
Phone: (215) 829-7704
Fax: (215) 829-6104
Patient appointments: 800-789-PENN (7366)

Related Links